The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin

Biophysical Journal

Volumn 97, Issue 12, 2009, Pages 3178-3186

  Mir, Rafia ^a   Singh, Nagendra ^a   Vikram, Gopalakrishnapillai ^a   Kumar, Ramasamy Prem ^a   Sinha, Mau ^a   Bhushan, Asha ^a   Kaur, Punit ^a   Srinivasan, Alagiri ^a   Sharma, Sujata ^a   Singh, Tej P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINAE;

EID: 73449126548     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.09.030     Document Type: Article

References (26)

1. Saverymuttu, S. H., A. Thomas, A. Grundy, and J. D. Maxwell. 1986. Ileal stricturing after long-term indomethacin treatment. Postgrad. Med. J. 62:967-968.
2. Bjarnason, I., J. Hayllar, A. J. MacPherson, and A. S. Russell. 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 104:1832-1847.
3. Tomisato, W., S. Tsutsumi, T. Hoshino, H. J. Hwang, M. Mio, et al. 2004. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem. Pharmacol. 67:575-585.
4. Tomisato, W., K. Tanaka, T. Katsu, H. Kakuta, K. Sasaki, et al. 2004. Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 323:1032-1039.
5. Scarpignato, C., I. Pelosini, F. Di, and Mario. 2006. Acid suppression therapy: where do we go from here? Dig. Dis. 24:11-46.
6. Yeomans, N., A. Lanas, J. Labenz, S. V. van Zanten, C. van Rensburg, et al. 2008. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am. J. Gastroenterol. 103:2465-2473.
7. Playford, R. J., D. N. Floyd, C. E. Macdonald, D. P. Calnan, R. O. Adenekan, et al. 1999. Bovine colostrums is a health food supplement which prevents NSAID induces gut damage. Gut. 44:653-658.
8. Playford, R. J., C. E. MacDonald, D. P. Calnan, D. N. Floyd, T. Podas, et al. 2001. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory druginduced increase in intestinal permeability. Clin. Sci. (Lond.). 100:627-633.
9. Troost, F. J., W. H. Saris, and R. J. Brummer. 2003. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers. Eur. J. Clin. Nutr. 57:1579-1585.
10. Dial, E. J., A. J. Dohrman, J. J. Romero, and L. M. Lichtenberger. 2005. Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J. Pharm. Pharmacol. 57:93-99.
11. Chen, X., J. C. Fan, Y. Wang, C. P. Fan, and Z. C. Shang. 2006. Fluorometric study on the interaction between lomefloxacin and bovine lactoferrin. Anal. Sci. 22:427-430.
12. Fan, J. C., X. Chen, Y. Wang, C. P. Fan, and Z. C. Shang. 2006. Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albumin. J. Zhejiang Univ. Sci. B. 7:452-458.
13. Sharma, S., T. P. Singh, and K. L. Bhatia. 1999. Preparation and characterization of the N and C monoferric lobes of buffalo lactoferrin produced by proteolysis using proteinase K. J. Dairy Res. 66:81-90.
14. Sharma, S., J. Jasti, J. Kumar, A. K. Mohanty, and T. P. Singh. 2003. Crystal structure of a proteolytically generated functional monoferric C-lobe of bovine lactoferrin at 1.9A resolution. J. Mol. Biol. 331:485-496.
15. Sharma, A. K., M. Paramsivam, A. Srinivasan, M. P. Yadav, and T. P. Singh. 1999. Three-dimensional structure of mare diferric lactoferrin at 2.6Å resolution. J. Mol. Biol. 289:303-318.
16. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
17. Crosby, W. H., and F. W. Furth. 1956. A modification of the benzidine method for measurement of hemoglobin in plasma and urine. Blood. 11:380-383.
18. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
19. Navaza, J. 1993. On the computation of the fast rotation function. Acta Crystallogr. D. Biol. Crystallogr. 49:588-591.
20. Perrakis, A., M. Harkiolaki, K. S. Wilson, and V. S. Lamzin. 2001. ARP/wARP and molecular replacement. Acta Crystallogr. D. Biol. Crystallogr. 57:1445-1450.
21. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr. 53:240-255.
22. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
23. Charland, M. B. 1995. Sigma Plot for Scientists. Wm. C. Brown Communications, Dubuque, IA.
24. Ghuman, J., P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri, et al. 2005. Structural basis of the drug binding specificity by human serum albumin. J. Mol. Biol. 353:38-52.
25. Olsen, H., A. Andersen, A. Nordbø, U. E. Kongsgaard, and O. P. Børmer. 2004. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro. BMC Clin. Pharmacol. 4:4.
26. Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:281-296.